Gufic BioScience

{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "441.85",
    "chg": 6.25,
    "chgp": "1.43%",
    "dir": 1,
    "prev_price": "435.60",
    "mcapval": "4,430.98 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE742B01025",
    "curr_date": "Sep 21, 11:36 AM",
    "curr_time": "11:37 AM",
    "last_traded_at": "Sep 21, 11:36 AM IST",
    "bse_nse_vol": "43.28 k",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-hold-by-marketsmojo-4193448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GuficBioScience_mojoScore_4193448.png",
        "date": "2026-09-15 10:10:05",
        "description": "Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gufic BioSciences Ltd to 52-Week High of Rs 466.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-hits-new-52-week-high-at-rs46605-4184510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GuficBioScience_priceRelatedfactors_4184510.png",
        "date": "2026-09-07 09:57:41",
        "description": "Surging past its previous peak, Gufic BioSciences Ltd touched a fresh 52-week high of Rs 466.05 on 7 Sep 2026, marking a notable milestone in its price momentum. This advance comes amid a six-day winning streak that has propelled the stock up by nearly 14%, significantly outperforming its sector and the broader market."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-hold-by-marketsmojo-4182569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GuficBioScience_mojoScore_4182569.png",
        "date": "2026-09-04 10:10:05",
        "description": "Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gufic BioSciences Ltd to 52-Week High of Rs 448.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-hits-new-52-week-high-at-rs4487-4179801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GuficBioScience_priceRelatedfactors_4179801.png",
        "date": "2026-09-02 12:35:22",
        "description": "With a decisive break above Rs 448.7 on 2 Sep 2026, Gufic BioSciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly subdued market backdrop."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-hold-by-marketsmojo-4166901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GuficBioScience_mojoScore_4166901.png",
        "date": "2026-08-24 10:10:04",
        "description": "Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Gufic BioSciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gufic-biosciences-ltd-latest-results-good-or-bad-4154701",
        "imagepath": "",
        "date": "2026-08-14 19:49:20",
        "description": "Gufic BioSciences Ltd's latest financial results for Q4 FY26 indicate a notable recovery in operational performance compared to previous periods. The company reported a net profit of ₹21.90 crores, reflecting a significant year-on-year increase of 183.68%. Revenue for the quarter also showed robust growth, reaching ₹251.82 crores, which is a 22.83% increase year-on-year and an 8.82% increase compared to the previous quarter. \n\nThe operating margin improved to 18.75%, marking the highest level in seven quarters, and the profit after tax (PAT) margin rose to 8.70%, up 4.93 percentage points year-on-year. This improvement in margins suggests enhanced operational efficiency and better cost management.\n\nDespite these positive indicators, the company faced challenges in the preceding fiscal year, with a decline in net profit of 19.77% for FY25 compared to FY24, primarily due to rising interest costs. The long-ter..."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-hold-by-marketsmojo-4151779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GuficBioScience_mojoScore_4151779.png",
        "date": "2026-08-13 10:10:05",
        "description": "Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 August 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "When is the next results date for Gufic BioSciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gufic-biosciences-ltd-4148714",
        "imagepath": "",
        "date": "2026-08-11 23:17:14",
        "description": "The next results date for Gufic BioSciences Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4134478",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GuficBioScience_technicaldot_4134478.png",
        "date": "2026-08-04 08:02:59",
        "description": "Gufic BioSciences Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from mildly bullish to bullish territory. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, reflects improving investor sentiment amid a backdrop of steady price appreciation and robust long-term returns."
      }
    ],
    "total": 600,
    "sid": "338998",
    "stock_news_url": "https://www.marketsmojo.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "08-Sep-2026",
      "details": "Intimation of Credit Rating is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "07-Sep-2026",
      "details": "Voting Results and Consolidated Scrutinizer Report of 42nd Annual General Meeting of the Company held on Friday September 04 2026 is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "04-Sep-2026",
      "details": "Proceedings of the 42nd Annual General Meeting of the Company held on Friday September 04 2026 is attached herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 28 Aug 26",
          "dt": "2026-08-28",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gufic BioSciences Ltd is Rated Hold by MarketsMOJO

2026-09-15 10:10:05

Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Gufic BioSciences Ltd to 52-Week High of Rs 466.05

2026-09-07 09:57:41

Surging past its previous peak, Gufic BioSciences Ltd touched a fresh 52-week high of Rs 466.05 on 7 Sep 2026, marking a notable milestone in its price momentum. This advance comes amid a six-day winning streak that has propelled the stock up by nearly 14%, significantly outperforming its sector and the broader market.

Read full news article

Gufic BioSciences Ltd is Rated Hold by MarketsMOJO

2026-09-04 10:10:05

Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Broad-Based Technical Strength Lifts Gufic BioSciences Ltd to 52-Week High of Rs 448.7

2026-09-02 12:35:22

With a decisive break above Rs 448.7 on 2 Sep 2026, Gufic BioSciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly subdued market backdrop.

Read full news article

Gufic BioSciences Ltd is Rated Hold by MarketsMOJO

2026-08-24 10:10:04

Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Gufic BioSciences Ltd latest results good or bad?

2026-08-14 19:49:20

Gufic BioSciences Ltd's latest financial results for Q4 FY26 indicate a notable recovery in operational performance compared to previous periods. The company reported a net profit of ₹21.90 crores, reflecting a significant year-on-year increase of 183.68%. Revenue for the quarter also showed robust growth, reaching ₹251.82 crores, which is a 22.83% increase year-on-year and an 8.82% increase compared to the previous quarter. The operating margin improved to 18.75%, marking the highest level in seven quarters, and the profit after tax (PAT) margin rose to 8.70%, up 4.93 percentage points year-on-year. This improvement in margins suggests enhanced operational efficiency and better cost management. Despite these positive indicators, the company faced challenges in the preceding fiscal year, with a decline in net profit of 19.77% for FY25 compared to FY24, primarily due to rising interest costs. The long-ter...

Read full news article

Gufic BioSciences Ltd is Rated Hold by MarketsMOJO

2026-08-13 10:10:05

Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

When is the next results date for Gufic BioSciences Ltd?

2026-08-11 23:17:14

The next results date for Gufic BioSciences Ltd is scheduled for 14 August 2026....

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-04 08:02:59

Gufic BioSciences Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from mildly bullish to bullish territory. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, reflects improving investor sentiment amid a backdrop of steady price appreciation and robust long-term returns.

Read full news article

View All News